Preprint / Version 1

Shank3 deficiency severely dampens calcium buffer capacity in dopaminergic neurons from the ventral tegmental area

This article is a preprint and has not been certified by peer review.

Authors

Categories
Keywords
autism; Shank3; calcium buffer capacity; ventral tegmental area; dopaminergic neuron; parvalbumin

Abstract

The intracellular calcium buffer system plays a critical role in shaping the spatiotemporal profile of calcium signaling. In contrast to calcium influx and clearance from the cytosol, our understanding of the calcium buffer system and its role in neuropsychiatric disorders is limited. Shank3 deficiency is a key risk factor for autism and other psychiatric disorders, and many important downstream mechanisms, relating to signaling pathways, cellular physiology and morphology, and neuronal circuitry, have been uncovered. Here we report prominent alterations in the calcium signaling profile of Shank3-/- dopaminergic (DA) neurons in the ventral tegmental area (VTA). Calcium transients from Shank3-/- DA neurons exhibit enhanced amplitudes and faster decay rates. Subsequent proteomic analysis of VTA brain tissue revealed that parvalbumin (PV) expression was significantly downregulated, which was subsequently confirmed by immunostaining results. As PV is an important component of the endogenous calcium buffer system, we employed the added-buffer approach together with 2-photon and ratiometric calcium and demonstrated a reduction in the endogenous calcium buffer capacity (KE) in Shank3-/- neurons. Therefore, the downregulation of PV protein and the associated decrease in calcium buffer capacity are key pathogenic factors resulting from Shank3 deficiency.

References

Bariselli S, Contestabile A, Tzanoulinou S, Musardo S, Bellone C (2018) SHANK3 Downregulation in the Ventral Tegmental Area Accelerates the Extinction of Contextual Associations Induced by Juvenile Non-familiar Conspecific Interaction. Front Mol Neurosci 11:360.

Bariselli S, Tzanoulinou S, Glangetas C, Prevost-Solie C, Pucci L, Viguie J, Bezzi P, O'Connor EC, Georges F, Luscher C, Bellone C (2016) SHANK3 controls maturation of social reward circuits in the VTA. Nat Neurosci 19:926-934.

Brinley FJ, Jr. (1978) Calcium buffering in squid axons. Annu Rev Biophys Bioeng 7:363-392.

Clapham DE (2007) Calcium signaling. Cell 131:1047-1058.

Cohen JY, Haesler S, Vong L, Lowell BB, Uchida N (2012) Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 482:85-88.

Collin T, Chat M, Lucas MG, Moreno H, Racay P, Schwaller B, Marty A, Llano I (2005) Developmental changes in parvalbumin regulate presynaptic Ca2+ signaling. J Neurosci 25:96-107.

Combe CL, Gasparini S (2021) I(h) from synapses to networks: HCN channel functions and modulation in neurons. Prog Biophys Mol Biol 166:119-132.

Contractor A, Ethell IM, Portera-Cailliau C (2021) Cortical interneurons in autism. Nat Neurosci 24:1648-1659.

Delling JP, Boeckers TM (2021) Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications. J Neurodev Disord 13:55.

Delvendahl I, Jablonski L, Baade C, Matveev V, Neher E, Hallermann S (2015) Reduced endogenous Ca2+ buffering speeds active zone Ca2+ signaling. Proc Natl Acad Sci U S A 112:E3075-3084.

Drapeau E, Riad M, Kajiwara Y, Buxbaum JD (2018) Behavioral Phenotyping of an Improved Mouse Model of Phelan-McDermid Syndrome with a Complete Deletion of the Shank3 Gene. eNeuro 5.

Durand CM et al. (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:25-27.

Eisner D, Neher E, Taschenberger H, Smith G (2023) Physiology of intracellular calcium buffering. Physiol Rev 103:2767-2845.

Enomoto M, Nishikawa T, Siddiqui N, Chung S, Ikura M, Stathopulos PB (2017) From Stores to Sinks: Structural Mechanisms of Cytosolic Calcium Regulation. Adv Exp Med Biol 981:215-251.

Evans RC, Blackwell KT (2015) Calcium: amplitude, duration, or location? Biol Bull 228:75-83.

Fakler B, Adelman JP (2008) Control of K(Ca) channels by calcium nano/microdomains. Neuron 59:873-881.

Filice F, Janickova L, Henzi T, Bilella A, Schwaller B (2020) The Parvalbumin Hypothesis of Autism Spectrum Disorder. Front Cell Neurosci 14:577525.

Franconville R, Revet G, Astorga G, Schwaller B, Llano I (2011) Somatic calcium level reports integrated spiking activity of cerebellar interneurons in vitro and in vivo. J Neurophysiol 106:1793-1805.

Halbedl S, Schoen M, Feiler MS, Boeckers TM, Schmeisser MJ (2016a) Shank3 is localized in axons and presynaptic specializations of developing hippocampal neurons and involved in the modulation of NMDA receptor levels at axon terminals. J Neurochem 137:26-32.

Halbedl S, Schoen M, Feiler MS, Boeckers TM, Schmeisser MJ (2016b) Shank3 is localized in axons and presynaptic specializations of developing hippocampal neurons and involved in the modulation of NMDA receptor levels at axon terminals. J Neurochem 137:26-32.

Han QJ, Kim YH, Wang XM, Liu D, Zhang ZJ, Bey AL, Lay M, Chang W, Berta T, Zhang Y, Jiang YH, Ji RR (2016) SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons. Neuron 92:1279-1293.

Helmchen F, Tank DW (2015) A single-compartment model of calcium dynamics in nerve terminals and dendrites. Cold Spring Harb Protoc 2015:155-167.

Hou P, Xiao F, Liu H, Yuchi M, Zhang G, Wu Y, Wang W, Zeng W, Ding M, Cui J, Wu Z, Wang LY, Ding J (2016) Extrapolating microdomain Ca(2+) dynamics using BK channels as a Ca(2+) sensor. Sci Rep 6:17343.

Hu H, Gan J, Jonas P (2014) Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science 345:1255263.

Janickova L, Rechberger KF, Wey L, Schwaller B (2020) Absence of parvalbumin increases mitochondria volume and branching of dendrites in inhibitory Pvalb neurons in vivo: a point of convergence of autism spectrum disorder (ASD) risk gene phenotypes. Mol Autism 11:47.

Jedrzejewska-Szmek J, Dorman DB, Blackwell KT (2023) Making time and space for calcium control of neuron activity. Curr Opin Neurobiol 83:102804.

Jung S, Chung Y, Lee Y, Lee Y, Cho JW, Shin EJ, Kim HC, Oh YJ (2019) Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP(+)-induced neuronal death. Cell Death Discov 5:130.

Kumar P, Goettemoeller AM, Espinosa-Garcia C, Tobin BR, Tfaily A, Nelson RS, Natu A, Dammer EB, Santiago JV, Malepati S, Cheng L, Xiao H, Duong DD, Seyfried NT, Wood LB, Rowan MJM, Rangaraju S (2024) Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer's pathology. Nat Commun 15:2823.

Leblond CS et al. (2014) Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genet 10:e1004580.

Leybaert L, Sanderson MJ (2012) INTERCELLULAR Ca

WAVES: MECHANISMS AND FUNCTION. Physiol Rev 92:1359-1392.

Ma X, Miraucourt LS, Qiu H, Sharif-Naeini R, Khadra A (2023) Modulation of SK Channels via Calcium Buffering Tunes Intrinsic Excitability of Parvalbumin Interneurons in Neuropathic Pain: A Computational and Experimental Investigation. J Neurosci 43:5608-5622.

Maravall M, Mainen ZF, Sabatini BL, Svoboda K (2000) Estimating intracellular calcium concentrations and buffering without wavelength ratioing. Biophys J 78:2655-2667.

Matthews EA, Dietrich D (2015) Buffer mobility and the regulation of neuronal calcium domains. Front Cell Neurosci 9:48.

Morales M, Margolis EB (2017) Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci 18:73-85.

Nanou E, Catterall WA (2018) Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease. Neuron 98:466-481.

Pchitskaya E, Popugaeva E, Bezprozvanny I (2018) Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 70:87-94.

Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437-442.

Ruden JB, Dugan LL, Konradi C (2021) Parvalbumin interneuron vulnerability and brain disorders. Neuropsychopharmacology 46:279-287.

Santoro B, Shah MM (2020) Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders. Annu Rev Pharmacol Toxicol 60:109-131.

Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction and reward. Science 275:1593-1599.

Schwaller B (2020) Cytosolic Ca(2+) Buffers Are Inherently Ca(2+) Signal Modulators. Cold Spring Harb Perspect Biol 12.

Tang X, Jaenisch R, Sur M (2021) The role of GABAergic signalling in neurodevelopmental disorders. Nat Rev Neurosci 22:290-307.

Wang X, Xu Q, Bey AL, Lee Y, Jiang YH (2014) Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism 5:30.

Wang X et al. (2016) Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat Commun 7:11459.

Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, Sudhof TC (2016) Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science 352:aaf2669.

Zhou Z, Neher E (1993) Mobile and immobile calcium buffers in bovine adrenal chromaffin cells. J Physiol 469:245-273.

Zhu M, Idikuda VK, Wang J, Wei F, Kumar V, Shah N, Waite CB, Liu Q, Zhou L (2018) Shank3-deficient thalamocortical neurons show HCN channelopathy and alterations in intrinsic electrical properties. J Physiol 596:1259-1276.

Metrics

Views: 21
Downloads: 5

Downloads

Posted

2026-05-11

How to Cite

Lü, L., Lai, Y., Sun, R., Liu, R., Lai, J., Zhu, M., Chen, Y., Liu, Q., & Zhou, L. (2026). Shank3 deficiency severely dampens calcium buffer capacity in dopaminergic neurons from the ventral tegmental area. LangTaoSha Preprint Server. https://doi.org/10.65215/LTSpreprints.2026.05.11.000237

Download Citation

Declaration of Competing Interests

The authors declare no competing interests to disclose.